Tamoxifen as a therapeutic agent in acromegaly

被引：0
|
作者：
Irida Balili
Ariel Barkan
机构：
[1] University of Michigan,Division of Metabolism, Endocrinology and Diabetes
[2] University of Michigan,Department of Neurosurgery
来源：
Pituitary | 2014年 / 17卷
关键词：
Growth hormone; IGF-1; Estrogen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：500 / 504
页数：4
相关论文
共 50 条
  • [21] Pregnancy in acromegaly: Successful therapeutic outcome
    Herman-Bonert, V
    Seliverstov, M
    Melmed, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03): : 727 - 731
  • [22] Acromegaly: Role of Surgery in the Therapeutic Armamentarium
    Guinto, Gerardo
    Abdo, Miguel
    Zepeda, Erick
    Arechiga, Norma
    Mercado, Moises
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2012, 2012
  • [23] ACROMEGALY - CLINICAL ASPECTS AND THERAPEUTIC CRITERIA
    MICHAUD, P
    ZLATAR, N
    CLAURE, H
    RIESCO, J
    REVISTA MEDICA DE CHILE, 1972, 100 (06) : 625 - &
  • [24] A Consensus Statement on acromegaly therapeutic outcomes
    Melmed, Shlomo
    Bronstein, Marcello D.
    Chanson, Philippe
    Klibanski, Anne
    Casanueva, Felipe F.
    Wass, John A. H.
    Strasburger, Christian J.
    Luger, Anton
    Clemmons, David R.
    Giustina, Andrea
    NATURE REVIEWS ENDOCRINOLOGY, 2018, 14 (09) : 552 - 561
  • [25] A Consensus Statement on acromegaly therapeutic outcomes
    Shlomo Melmed
    Marcello D. Bronstein
    Philippe Chanson
    Anne Klibanski
    Felipe F. Casanueva
    John A. H. Wass
    Christian J. Strasburger
    Anton Luger
    David R. Clemmons
    Andrea Giustina
    Nature Reviews Endocrinology, 2018, 14 : 552 - 561
  • [26] Tamoxifen-Duloxetine: Risk of Reduced Therapeutic Response of Tamoxifen
    Mahe, J.
    Veyrac, G.
    Mathevet, J.
    Jolliet, P.
    DRUG SAFETY, 2011, 34 (10) : 933 - 934
  • [27] Tamoxifen-duloxetine: risk of reduced therapeutic response of tamoxifen
    Mahe, J.
    Veyrac, G.
    Mathevet, J. Y.
    Jolliet, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 101 - 101
  • [28] Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives
    Shagufta
    Ahmad, Irshad
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 143 : 515 - 531
  • [29] Octreotide may act as a radioprotective agent in acromegaly
    Landolt, AM
    Haller, D
    Lomax, N
    Scheib, S
    Schubiger, O
    Siegfried, J
    Wellis, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03): : 1287 - 1289
  • [30] Recurrent acromegaly: a systematic review on therapeutic approaches
    Seyed Farzad Maroufi
    Mohammadmahdi Sabahi
    Seyed Sahab Aarabi
    Mohammad Samadian
    Rocco Dabecco
    Badih Adada
    Karla M. Arce
    Hamid Borghei-Razavi
    BMC Endocrine Disorders, 24
12345